Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors | 06/20 08:00 | businesswire.com |
Arcturus: A Hidden Gem In The Biotech Sector | 06/08 02:42 | seekingalpha.com |
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference | 06/07 10:30 | businesswire.com |
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program | 05/28 06:30 | businesswire.com |
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine | 05/20 08:30 | businesswire.com |
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences | 05/15 16:01 | businesswire.com |
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for | 05/01 11:05 | zacks.com |
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 | 04/25 16:01 | businesswire.com |
Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2023 Earnings Call Transcript | 03/07 18:32 | seekingalpha.com |